In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Triazolam Drug Master File in Korea (Triazolam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Triazolam. The MFDS reviews the Triazolam KDMF as part of the drug registration process and uses the information provided in the Triazolam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Triazolam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Triazolam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Triazolam suppliers with KDMF on PharmaCompass.